Tabletop Fire Pit Lawsuit Individuals who suffered severe burns, or families who lost a loved one in a tabletop fire pit explosion, may be eligible for financial compensation through a fire pit injury lawsuit.
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Sports Betting Addiction Lawsuit Sports betting addiction lawsuits are being investigated for college students and young adults who developed gambling problems after using apps like FanDuel and DraftKings, alleging that the platforms failed to warn about the addictive nature of their features and marketing practices.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Change Healthcare Lawsuit Lawyers are reviewing Change Healthcare class action lawsuits for individuals who had their personal information stolen due to the data breach.
Bard PowerPort Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
AngioDynamics Port Catheter Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
KY Jelly Recall Issued Over Products Not Properly Approved For Sale March 11, 2013 Irvin Jackson Add Your Comments Johnson & Johnson has recalled more than two million containers of K-Y personal lubricants, after federal health officials notified the company that they were not properly approved to be on the market. The company announced a K-Y Tingling Jelly recall, a K-Y Sensitive Jelly recall, and a K-Y Silk-E Vaginal Moisturizer and Personal Lubricant recall late last month, although news of the products being removed from the market was just reported by media outlets late last week. According to a small notice placed on Johnson & Johnson’s K-Y website, the products were removed from the market because “each of these three K-Y products may require submission of new data to support a new medical device clearance, known as a 510(k).” Do You Know about… SPORTS BETTING ADDICTION LAWSUITS FOR YOUNG ADULTS Gambling addiction and severe financial losses have been linked to popular sports betting platforms like DraftKings, FanDuel, and Caesars. Lawsuits are being filed by young adults and students who were targeted by deceptive promotions, addictive app features, and aggressive marketing tactics. See if you qualify for a sports betting addiction lawsuit. Learn More SEE IF YOU QUALIFY FOR COMPENSATION Do You Know About… SPORTS BETTING ADDICTION LAWSUITS FOR YOUNG ADULTS Gambling addiction and severe financial losses have been linked to popular sports betting platforms like DraftKings, FanDuel, and Caesars. Lawsuits are being filed by young adults and students who were targeted by deceptive promotions, addictive app features, and aggressive marketing tactics. See if you qualify for a sports betting addiction lawsuit. Learn More SEE IF YOU QUALIFY FOR COMPENSATION The 510(k) approval process, often referred to as the fast-track approval process, allows approval of any medical device that is substantially equivalent to one already on the market. The program has been considered controversial because the definition of what is substantially equivalent appears to have become less and less defined over the years, and it has been used to approve major medical devices that were later found to be defective and deadly, but were never put through clinical trials before being sold. The FDA has determined that these K-Y Tingling Jelly, Sensitive Jelly and Silk-E moisturizer have been significantly changed or modified to the point that they could no longer claim to be substantially equivalent to previously approved products. Johnson & Johnson indicates that it has no plans to bring the products back to the market. The recall affected nearly 1.2 million units of Sensitive Jelly packed in 3 oz tubes with a UPC code of 380040085503. The recall also affects about 425,000 units of K-Y Tingling Jelly sold in 5 oz. tubes with a UPC code of 380040088887. The Silk-E recall affects more than 750,000 2.5 oz tubes packed in printed cartons with a UPC code of 380040087149 printed on the carton. There are no known health risks associated with any of the recalled products, and consumers have not been directed to stop using them. However, the products have been removed from store shelves and will no longer be available for sale. Written by: Irvin Jackson Senior Legal Journalist & Contributing Editor Irvin Jackson is a senior investigative reporter at AboutLawsuits.com with more than 30 years of experience covering mass tort litigation, environmental policy, and consumer safety. He previously served as Associate Editor at Inside the EPA and contributes original reporting on product liability lawsuits, regulatory failures, and nationwide litigation trends. Tags: Johnson & Johnson, K-Y More Lawsuit Stories Talcum Powder Ovarian Cancer Settlement Negotiations Set To Kick Off Sept. 4 August 27, 2025 Tepezza Hearing Loss Trial Date Pushed Back to Aug. 2026 August 27, 2025 More Than 16B Passwords Leaked in Data Breaches: Report August 27, 2025 2 Comments Jemme February 27, 2024 I use this type of personal lubricant and I had a friend that says that it irritated her and me also. Christal November 29, 2020 I will never use the kay y tingling is a big no no I hurt so bad Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA TermEmailThis field is for validation purposes and should be left unchanged. Δ MORE TOP STORIES Talcum Powder Ovarian Cancer Settlement Negotiations Set To Kick Off Sept. 4 (Posted: today) A federal judge has ordered parties involved in talcum powder ovarian cancer lawsuits to meet on September 4 to begin settlement negotiations. MORE ABOUT: TALCUM POWDER CANCER LAWSUITSWomen Will Have Voice in Any Settlement for Talcum Powder Lawsuits: Court (08/07/2025)Baby Powder Mesothelioma Lawsuit Ends in $42.6M Verdict for Massachusetts Family (08/01/2025)Talcum Powder Injury Lawyers Appointed To Negotiate Settlements With J&J (07/30/2025) Bard PowerPort Lawsuit Bellwether Trials Set To Begin March 2, 2026 (Posted: yesterday) A federal judge has released a schedule of the first six Bard PowerPort bellwether trials, which will be held throughout 2026. MORE ABOUT: BARD POWERPORT LAWSUITVancomycin May Increase Risk of Midline Catheter Complications: Study (08/13/2025)Chemo Port Infection Lawsuits Over Bard, AngioDynamics Catheters Allege Faulty Design Promotes Bacterial Growth (08/08/2025)Bard PowerPort Infection Lawsuit Chosen for First Bellwether Trial in Feb. 2026 (07/18/2025) Nearly 1,000 Depo-Provera Meningioma Lawsuits Filed, With Another 9,500 Under Investigation (Posted: 2 days ago) A federal judge continues to urge Depo-Provera meningioma lawsuit attorneys to submit unfiled claims, warning they may interfere with settlement negotiations, and that holding back on cases could threaten their leadership positions in the litigation. MORE ABOUT: DEPO-PROVERA LAWSUITExperts Weigh In On Depo-Provera Brain Tumor Risks, As Lawsuits Continue to Mount (08/20/2025)Woman Will Need Lifelong Monitoring After Depo-Provera Brain Tumor: Lawsuit (08/13/2025)Depo-Provera Brain Tumor Caused Numbness Over Half of Woman’s Body, Lawsuit Alleges (08/01/2025)
Talcum Powder Ovarian Cancer Settlement Negotiations Set To Kick Off Sept. 4 (Posted: today) A federal judge has ordered parties involved in talcum powder ovarian cancer lawsuits to meet on September 4 to begin settlement negotiations. MORE ABOUT: TALCUM POWDER CANCER LAWSUITSWomen Will Have Voice in Any Settlement for Talcum Powder Lawsuits: Court (08/07/2025)Baby Powder Mesothelioma Lawsuit Ends in $42.6M Verdict for Massachusetts Family (08/01/2025)Talcum Powder Injury Lawyers Appointed To Negotiate Settlements With J&J (07/30/2025)
Bard PowerPort Lawsuit Bellwether Trials Set To Begin March 2, 2026 (Posted: yesterday) A federal judge has released a schedule of the first six Bard PowerPort bellwether trials, which will be held throughout 2026. MORE ABOUT: BARD POWERPORT LAWSUITVancomycin May Increase Risk of Midline Catheter Complications: Study (08/13/2025)Chemo Port Infection Lawsuits Over Bard, AngioDynamics Catheters Allege Faulty Design Promotes Bacterial Growth (08/08/2025)Bard PowerPort Infection Lawsuit Chosen for First Bellwether Trial in Feb. 2026 (07/18/2025)
Nearly 1,000 Depo-Provera Meningioma Lawsuits Filed, With Another 9,500 Under Investigation (Posted: 2 days ago) A federal judge continues to urge Depo-Provera meningioma lawsuit attorneys to submit unfiled claims, warning they may interfere with settlement negotiations, and that holding back on cases could threaten their leadership positions in the litigation. MORE ABOUT: DEPO-PROVERA LAWSUITExperts Weigh In On Depo-Provera Brain Tumor Risks, As Lawsuits Continue to Mount (08/20/2025)Woman Will Need Lifelong Monitoring After Depo-Provera Brain Tumor: Lawsuit (08/13/2025)Depo-Provera Brain Tumor Caused Numbness Over Half of Woman’s Body, Lawsuit Alleges (08/01/2025)